Dr Lal Pathlabs

{
  "main_header": {
    "sid": 1000163,
    "name": "Dr Lal Pathlabs",
    "stock_name": "Dr Lal Pathlabs",
    "full_name": "Dr Lal Pathlabs Ltd",
    "name_url": "stocks-analysis/dr-lal-pathlabs",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,400.40",
    "chg": -1,
    "chgp": "-0.07%",
    "dir": -1,
    "prev_price": "1,401.40",
    "mcapval": "23,272.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 539524,
    "symbol": "LALPATHLAB",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE600L01024",
    "curr_date": "Jan 28",
    "curr_time": "",
    "bse_nse_vol": "1.81 lacs",
    "exc_status": "Active",
    "traded_date": "Jan 28, 2026",
    "traded_date_str": "2026 01 28",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dr-lal-pathlabs-1000163-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Dr Lal Pathlabs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dr-lal-pathlabs-ltd-is-rated-sell-3795949",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/DrLalPathlabsLt_mojoScore_3795949.png",
        "date": "2026-01-20 10:10:04",
        "description": "Dr Lal Pathlabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Dr Lal Pathlabs Ltd Forms Death Cross, Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-ltd-forms-death-cross-signalling-potential-bearish-trend-3792244",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/DrLalPathlabsLt_dealthcross_3792244.png",
        "date": "2026-01-14 18:00:39",
        "description": "Dr Lal Pathlabs Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock's medium to long-term outlook within the healthcare services sector."
      },
      {
        "title": "Why is Dr Lal Pathlabs Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dr-lal-pathlabs-ltd-fallingrising-3790421",
        "imagepath": "",
        "date": "2026-01-13 01:18:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>The stock has been on a downward trajectory for the past three consecutive days, accumulating a loss of 6.04% over this period. This decline is sharper than the sector’s average, with Dr Lal Pathlabs underperforming by 1.25% on the day. When compared to the broader market, the stock’s weekly return of -7.47% starkly contrasts with the Sensex’s more modest decline of -1.83%. Similarly, over the one-month and year-to-date periods, the stock has fallen by 3.23% and 6.20% respectively, while the Sensex has only dipped by 1.63% and 1.58% in the same intervals. This persistent underperformance highlights growing investor concerns specific to Dr Lal Pathlabs amid a relatively stable benchmark environment.</p>\n<p><strong>Technical Indicator..."
      },
      {
        "title": "Dr Lal Pathlabs Declines 3.77%: Mixed Technicals and Downgrade Shape Weekly Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-declines-377-mixed-technicals-and-downgrade-shape-weekly-trend-3788290",
        "imagepath": "",
        "date": "2026-01-10 14:00:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 5:</strong> Technical momentum shifts amid mixed market signals</p>\n                    <p><strong>Jan 6:</strong> Technical trend briefly turns mildly bullish</p>\n                    <p><strong>Jan 8-9:</strong> Downgrade to Sell and renewed bearish technical outlook</p>\n                    <p><strong>Jan 9:</strong> Week closes at Rs.1,417.00 (-3.77%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,502.25</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,417.00</div><div cl..."
      },
      {
        "title": "Dr Lal Pathlabs Downgraded to Sell Amid Mixed Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dr-lal-pathlabs-downgraded-to-sell-amid-mixed-financials-and-bearish-technicals-3786493",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/DrLalPathlabsLt_mojoScore_3786493.png",
        "date": "2026-01-09 08:12:17",
        "description": "Dr Lal Pathlabs Ltd, a prominent player in the healthcare services sector, has seen its investment rating downgraded from Hold to Sell as of 8 January 2026. This shift reflects a combination of deteriorating technical indicators, valuation pressures, and subdued long-term financial growth, despite recent positive quarterly results. The downgrade, reflected in a MarketsMOJO Mojo Score of 48.0, signals caution for investors amid mixed signals across quality, valuation, financial trends, and technical parameters."
      },
      {
        "title": "Dr Lal Pathlabs Ltd Faces Technical Momentum Shift Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-ltd-faces-technical-momentum-shift-amid-bearish-signals-3786389",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/DrLalPathlabsLt_technicaldot_3786389.png",
        "date": "2026-01-09 08:07:48",
        "description": "Dr Lal Pathlabs Ltd, a prominent player in the healthcare services sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend. This change is underscored by a combination of weakening technical indicators and a recent downgrade in its Mojo Grade to Sell, reflecting growing investor caution amid broader market pressures."
      },
      {
        "title": "Dr Lal Pathlabs Ltd Shows Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-ltd-shows-technical-momentum-shift-amid-mixed-market-signals-3782632",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/DrLalPathlabsLt_technicaldot_3782632.png",
        "date": "2026-01-06 08:30:58",
        "description": "Dr Lal Pathlabs Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend, supported by a blend of mixed signals from key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands. This nuanced change comes amid a backdrop of steady price appreciation and evolving market sentiment within the healthcare services sector."
      },
      {
        "title": "Dr Lal Pathlabs Ltd Faces Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-ltd-faces-technical-momentum-shift-amid-mixed-market-signals-3780985",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/DrLalPathlabsLt_technicaldot_3780985.png",
        "date": "2026-01-05 08:07:51",
        "description": "Dr Lal Pathlabs Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish to a mildly bearish trend as of early January 2026. Despite a recent downgrade from a Sell to a Hold rating by MarketsMOJO, the stock’s mixed technical indicators suggest a complex outlook for investors navigating the healthcare services sector."
      },
      {
        "title": "Dr Lal Pathlabs Gains 4.77%: 2 Key Factors Driving the Weekly Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-gains-477-2-key-factors-driving-the-weekly-momentum-3779590",
        "imagepath": "",
        "date": "2026-01-03 14:53:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>29 Dec 2025:</strong> Stock rises 1.71% to Rs.1,429.50 as Sensex declines</p>\n                    <p><strong>30 Dec 2025:</strong> Gains continue with 1.90% increase to Rs.1,456.70</p>\n                    <p><strong>31 Dec 2025:</strong> Further 1.74% rise to Rs.1,482.05 alongside Sensex rebound</p>\n                    <p><strong>1 Jan 2026:</strong> Technical upgrade announced; stock closes at Rs.1,508.90 (+1.81%)</p>\n                    <p><strong>2 Jan 2026:</strong> Stock retreats 2.41% to Rs.1,472.50 despite Sensex gains</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div cl..."
      }
    ],
    "total": 274,
    "sid": "1000163",
    "stock_news_url": "https://www.marketsmojo.com/news/dr-lal-pathlabs-1000163"
  },
  "announcements": [
    {
      "details": "Dr. Lal Path Labs Ltd. has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Dr. Lal Path Labs Ltd. - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Dr. Lal Path Labs Ltd. has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Dr. Lal Path Labs Ltd. - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "28-Nov-2019"
    },
    {
      "details": "Dr. Lal Path Labs Ltd. has informed the Exchange regarding Compliance under Regulation 23(9) : Please find enclosed Related Party Transaction for the half year ended September 30, 2019.",
      "source": "NSE",
      "caption": "Dr. Lal Path Labs Ltd. - Other General Purpose",
      "datetime": "22-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "30 Jan 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dr Lal Pathlabs Ltd has declared <strong>70%</strong> dividend, ex-date: 07 Nov 25",
          "dt": "2025-11-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Dr Lal Pathlabs Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 19 Dec 25",
          "dt": "2025-12-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Dr Lal Pathlabs Ltd is Rated Sell

2026-01-20 10:10:04

Dr Lal Pathlabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Dr Lal Pathlabs Ltd Forms Death Cross, Signalling Potential Bearish Trend

2026-01-14 18:00:39

Dr Lal Pathlabs Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock's medium to long-term outlook within the healthcare services sector.

Read full news article

Why is Dr Lal Pathlabs Ltd falling/rising?

2026-01-13 01:18:15

Recent Price Movement and Market Comparison

The stock has been on a downward trajectory for the past three consecutive days, accumulating a loss of 6.04% over this period. This decline is sharper than the sector’s average, with Dr Lal Pathlabs underperforming by 1.25% on the day. When compared to the broader market, the stock’s weekly return of -7.47% starkly contrasts with the Sensex’s more modest decline of -1.83%. Similarly, over the one-month and year-to-date periods, the stock has fallen by 3.23% and 6.20% respectively, while the Sensex has only dipped by 1.63% and 1.58% in the same intervals. This persistent underperformance highlights growing investor concerns specific to Dr Lal Pathlabs amid a relatively stable benchmark environment.

Technical Indicator...

Read full news article

Dr Lal Pathlabs Declines 3.77%: Mixed Technicals and Downgrade Shape Weekly Trend

2026-01-10 14:00:10

Key Events This Week

Jan 5: Technical momentum shifts amid mixed market signals

Jan 6: Technical trend briefly turns mildly bullish

Jan 8-9: Downgrade to Sell and renewed bearish technical outlook

Jan 9: Week closes at Rs.1,417.00 (-3.77%)

Week Open

Rs.1,502.25

Week Close

Rs.1,417.00

Read full news article

Dr Lal Pathlabs Downgraded to Sell Amid Mixed Financials and Bearish Technicals

2026-01-09 08:12:17

Dr Lal Pathlabs Ltd, a prominent player in the healthcare services sector, has seen its investment rating downgraded from Hold to Sell as of 8 January 2026. This shift reflects a combination of deteriorating technical indicators, valuation pressures, and subdued long-term financial growth, despite recent positive quarterly results. The downgrade, reflected in a MarketsMOJO Mojo Score of 48.0, signals caution for investors amid mixed signals across quality, valuation, financial trends, and technical parameters.

Read full news article

Dr Lal Pathlabs Ltd Faces Technical Momentum Shift Amid Bearish Signals

2026-01-09 08:07:48

Dr Lal Pathlabs Ltd, a prominent player in the healthcare services sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend. This change is underscored by a combination of weakening technical indicators and a recent downgrade in its Mojo Grade to Sell, reflecting growing investor caution amid broader market pressures.

Read full news article

Dr Lal Pathlabs Ltd Shows Technical Momentum Shift Amid Mixed Market Signals

2026-01-06 08:30:58

Dr Lal Pathlabs Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend, supported by a blend of mixed signals from key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands. This nuanced change comes amid a backdrop of steady price appreciation and evolving market sentiment within the healthcare services sector.

Read full news article

Dr Lal Pathlabs Ltd Faces Technical Momentum Shift Amid Mixed Market Signals

2026-01-05 08:07:51

Dr Lal Pathlabs Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish to a mildly bearish trend as of early January 2026. Despite a recent downgrade from a Sell to a Hold rating by MarketsMOJO, the stock’s mixed technical indicators suggest a complex outlook for investors navigating the healthcare services sector.

Read full news article

Dr Lal Pathlabs Gains 4.77%: 2 Key Factors Driving the Weekly Momentum

2026-01-03 14:53:00

Key Events This Week

29 Dec 2025: Stock rises 1.71% to Rs.1,429.50 as Sensex declines

30 Dec 2025: Gains continue with 1.90% increase to Rs.1,456.70

31 Dec 2025: Further 1.74% rise to Rs.1,482.05 alongside Sensex rebound

1 Jan 2026: Technical upgrade announced; stock closes at Rs.1,508.90 (+1.81%)

2 Jan 2026: Stock retreats 2.41% to Rs.1,472.50 despite Sensex gains

Week Open

Read full news article

View All News